Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
10.65
+0.25 (2.40%)
Apr 29, 2024, 4:00 PM EDT - Market closed
Treace Medical Concepts Revenue
In the year 2023, Treace Medical Concepts had annual revenue of $187.12M with 31.92% growth. Revenue in the quarter ending December 31, 2023 was $62.21M with 25.00% year-over-year growth.
Revenue (ttm)
$187.12M
Revenue Growth
+31.92%
P/S Ratio
3.51
Revenue / Employee
$362,632
Employees
516
Market Cap
657.69M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
Dec 31, 2019 | 39.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Pennant Group | 544.89M |
Pharming Group | 272.57M |
SIGA Technologies | 139.92M |
Y-mAbs Therapeutics | 84.82M |
Jin Medical International | 19.82M |
Stoke Therapeutics | 8.78M |
Dianthus Therapeutics | 2.83M |
TMCI News
- 5 days ago - Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour - GlobeNewsWire
- 12 days ago - Treace to Present at Bank of America Health Care Conference - GlobeNewsWire
- 13 days ago - Treace Announces First Annual National Bunion Day - GlobeNewsWire
- 20 days ago - Treace to Report First Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone - GlobeNewsWire
- 2 months ago - Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance - GlobeNewsWire
- 2 months ago - Treace to Report Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure - GlobeNewsWire